1. Antineoplastics

   Case report 01 April 2023 Pages: 51 - 51

2. Antineoplastics

   Case report 01 April 2023 Pages: 52 - 52

3. Antineoplastics

   Case report 01 April 2023 Pages: 53 - 53

4. Antineoplastics

   Case report 01 April 2023 Pages: 54 - 54

5. Antineoplastics

   Case report 01 April 2023 Pages: 55 - 55

6. Antineoplastics/CD30-antigen-inhibitors

   Case report 01 April 2023 Pages: 56 - 56

7. Antineoplastics/convalescent anti-SARS-CoV-2 plasma

   Case report 01 April 2023 Pages: 57 - 57

8. Antineoplastics/COVID-19-vaccine/Methylprednisolone

   Case report 01 April 2023 Pages: 58 - 58

9. Antineoplastics/programmed-cell-death-1-receptor-antagonists

   Case report 01 April 2023 Pages: 59 - 59

10. Antineoplastics/unspecified growth-factors/unspecified granulocyte-colony-stimulating-factors

    Case report 01 April 2023 Pages: 60 - 60

11. Antiretrovirals

    Case report 01 April 2023 Pages: 61 - 61

12. Antithrombin-III/enoxaparin-sodium/heparin/warfarin

    Case report 01 April 2023 Pages: 62 - 62

13. Antituberculars

    Case report 01 April 2023 Pages: 63 - 63

14. Antituberculars/levofloxacin

    Case report 01 April 2023 Pages: 64 - 64

15. Apixaban

    Case report 01 April 2023 Pages: 65 - 65

16. Apixaban

    Case report 01 April 2023 Pages: 66 - 66

17. Apixaban/enoxaparin-sodium

    Case report 01 April 2023 Pages: 67 - 67

18. Apixaban/warfarin

    Case report 01 April 2023 Pages: 68 - 68

19. Apremilast

    Case report 01 April 2023 Pages: 69 - 69

20. Ascorbic-acid/methotrexate

    Case report 01 April 2023 Pages: 70 - 70

21. Aspirin

    Case report 01 April 2023 Pages: 71 - 71

22. Aspirin

    Case report 01 April 2023 Pages: 72 - 72

23. Atezolizumab

    Case report 01 April 2023 Pages: 73 - 73

24. Atropine/ephedrine

    Case report 01 April 2023 Pages: 74 - 74

25. Axitinib/nivolumab/pazopanib

    Case report 01 April 2023 Pages: 75 - 75

26. Azathioprine

    Case report 01 April 2023 Pages: 76 - 76

27. Azd-1222

    Case report 01 April 2023 Pages: 77 - 77

28. Azd-1222

    Case report 01 April 2023 Pages: 78 - 78

29. Azd-1222/bbv-152

    Case report 01 April 2023 Pages: 79 - 79

30. AZD-1222/immune-globulin

    Case report 01 April 2023 Pages: 80 - 80

31. Azd-1222/influenza-virus-vaccine/tozinameran

    Case report 01 April 2023 Pages: 81 - 81

32. Azithromycin/hydroxychloroquine

    Case report 01 April 2023 Pages: 82 - 82

33. Baclofen/clonazepam

    Case report 01 April 2023 Pages: 83 - 83

34. Bbibp-corv

    Case report 01 April 2023 Pages: 84 - 84

35. BCG

    Case report 01 April 2023 Pages: 85 - 85

36. Bcg-vaccine

    Case report 01 April 2023 Pages: 86 - 86

37. BCG-vaccine

    Case report 01 April 2023 Pages: 87 - 87

38. Benzathine-benzylpenicillin

    Case report 01 April 2023 Pages: 88 - 88

39. Benzodiazepines/valproic-acid

    Case report 01 April 2023 Pages: 89 - 89

40. Betamethasone

    Case report 01 April 2023 Pages: 90 - 90

41. Bevacizumab

    Case report 01 April 2023 Pages: 91 - 91

42. Bevacizumab/cyclophosphamide

    Case report 01 April 2023 Pages: 92 - 92

43. Bevacizumab/immune-checkpoint-protein-inhibitors

    Case report 01 April 2023 Pages: 93 - 93

44. Bevacizumab/nedaplatin/pemetrexed

    Case report 01 April 2023 Pages: 94 - 94

45. Bevacizumab/temozolomide

    Case report 01 April 2023 Pages: 95 - 95

46. Bicalutamide/goserelin

    Case report 01 April 2023 Pages: 96 - 96

47. Bicarbonate/fomepizole

    Case report 01 April 2023 Pages: 97 - 97

48. Biperiden

    Case report 01 April 2023 Pages: 98 - 98

49. Bortezomib

    Case report 01 April 2023 Pages: 99 - 99

50. Bortezomib/imatinib

    Case report 01 April 2023 Pages: 100 - 100